Schonfeld Strategic Advisors LLC Novo Nordisk A S Transaction History

Schonfeld Strategic Advisors LLC

  • $15 Billion
  • Q1 2025

A detailed history of Schonfeld Strategic Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 156,635 shares of NVO stock, worth $11 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
156,635
Holding current value
$11 Million
% of portfolio
0.07%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$69.3 - $90.95 $10.9 Million - $14.2 Million
156,635 New
156,635 $10.9 Million
Q3 2024

Nov 14, 2024
BUY
$119.07 - $145.42 $8.45 Million - $10.3 Million
70,925 New
70,925 $8.45 Million
Q1 2024

May 15, 2024
BUY
$102.11 - $135.92 $326,752 - $434,943
3,200 New
3,200 $410,000
Q2 2023

Aug 14, 2023
SELL
$155.98 - $172.65 $155,980 - $172,650
-1,000 Reduced 90.91%
100 $16,000
Q1 2023

May 15, 2023
BUY
$132.34 - $159.14 $145,574 - $175,053
1,100 New
1,100 $175,000
Q3 2022

Nov 14, 2022
SELL
$95.28 - $116.93 $4.81 Million - $5.91 Million
-50,530 Reduced 93.01%
3,800 $379,000
Q2 2022

Aug 15, 2022
SELL
$103.24 - $121.81 $5.7 Million - $6.73 Million
-55,251 Reduced 50.42%
54,330 $6.05 Million
Q1 2022

May 16, 2022
BUY
$93.1 - $112.54 $10.2 Million - $12.3 Million
109,581 New
109,581 $12.2 Million
Q4 2021

Feb 14, 2022
SELL
$95.88 - $117.08 $4.98 Million - $6.08 Million
-51,942 Closed
0 $0
Q3 2021

Nov 16, 2021
BUY
$84.42 - $106.62 $2.13 Million - $2.69 Million
25,242 Added 94.54%
51,942 $4.99 Million
Q2 2021

Nov 16, 2021
SELL
$67.66 - $84.76 $74,426 - $93,236
-1,100 Reduced 3.96%
26,700 $2.24 Million
Q2 2021

Aug 16, 2021
SELL
$67.66 - $84.76 $2.12 Million - $2.66 Million
-31,374 Reduced 53.02%
27,800 $2.33 Million
Q1 2021

May 17, 2021
SELL
$67.06 - $75.82 $35,273 - $39,881
-526 Reduced 0.88%
59,174 $3.99 Million
Q4 2020

Feb 16, 2021
BUY
$63.89 - $73.8 $3.81 Million - $4.41 Million
59,700 New
59,700 $4.17 Million
Q1 2020

May 15, 2020
SELL
$49.46 - $64.78 $256,351 - $335,754
-5,183 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$49.86 - $58.26 $258,424 - $301,961
5,183 New
5,183 $300,000
Q4 2018

Feb 14, 2019
SELL
$41.54 - $47.25 $1.3 Million - $1.48 Million
-31,260 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$46.76 - $51.24 $9,258 - $10,145
198 Added 0.64%
31,260 $1.47 Million
Q2 2018

Aug 14, 2018
BUY
$44.29 - $50.42 $1.38 Million - $1.57 Million
31,062 New
31,062 $1.43 Million
Q4 2017

Feb 14, 2018
SELL
$47.53 - $53.73 $1.26 Million - $1.43 Million
-26,543 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$41.15 - $49.22 $1.09 Million - $1.31 Million
26,543
26,543 $1.28 Million

Others Institutions Holding NVO

# of Institutions
1,768
Shares Held
330M
Call Options Held
11.3M
Put Options Held
15.5M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $159B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email